Cargando…

Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)

Detalles Bibliográficos
Autores principales:	Asano, Aya, Ueda, Shigeto, Kuji, Ichiei, Yamane, Tomohiko, Takeuchi, Hideki, Hirokawa, Eiko, Sugitani, Ikuko, Shimada, Hiroko, Hasebe, Takahiro, Osaki, Akihiko, Saeki, Toshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123998/ https://www.ncbi.nlm.nih.gov/pubmed/30185224 http://dx.doi.org/10.1186/s13058-018-1038-3

Ejemplares similares

Intracellular hypoxia measured by (18)F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer
por: Asano, Aya, et al.
Publicado: (2018)

Optical Imaging for Monitoring Tumor Oxygenation Response after Initiation of Single-Agent Bevacizumab followed by Cytotoxic Chemotherapy in Breast Cancer Patients
por: Ueda, Shigeto, et al.
Publicado: (2014)

In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab
por: Ueda, Shigeto, et al.
Publicado: (2016)

Neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin administered every 3 weeks for Japanese women with HER2-positive primary breast cancer: efficacy and safety
por: Sugitani, Ikuko, et al.
Publicado: (2017)

Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast
por: Ueda, Shigeto, et al.
Publicado: (2013)

Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility study
por: Shigekawa, Takashi, et al.
Publicado: (2015)

Genomic Profiling Shows Increased Glucose Metabolism in Luminal B Breast Cancer
por: Ueda, Shigeto, et al.
Publicado: (2013)

Clinicopathological and prognostic impact of imaging of breast cancer angiogenesis and hypoxia using diffuse optical spectroscopy
por: Nakamiya, Noriko, et al.
Publicado: (2014)

Granuloma after breast conserving surgery—a report of three cases
por: Ichinose, Yuki, et al.
Publicado: (2021)

The Roles of Hypoxia Imaging Using (18)F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment
por: Hirata, Kenji, et al.
Publicado: (2019)

Diffuse FDG uptake in the bilateral lungs: hypersensitivity pneumonitis supported by low-dose CT findings
por: Goto, Shun, et al.
Publicado: (2022)

Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033)
por: Davies, Kalatu R., et al.
Publicado: (2016)

Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer
por: Kuji, Ichiei, et al.
Publicado: (2017)

Can the function of the tubarial glands be evaluated using [(99m)Tc]pertechnetate SPECT/CT, [(18)F]FDG PET/CT, and [(11)C]methionine PET/CT?
por: Matsusaka, Yohji, et al.
Publicado: (2021)

Atlas of non-pathological solitary or asymmetrical skeletal muscle uptake in [(18)F]FDG-PET
por: Yamane, Tomohiko, et al.
Publicado: (2022)

Quantification of bone metabolic activity in the natural course of fractural lesions measured by quantitative SPECT/CT
por: Yamane, Tomohiko, et al.
Publicado: (2023)

Early HER2-positive breast cancer arising from a fibroadenoma: a case report
por: Fujimoto, Akihiro, et al.
Publicado: (2021)

(18)F-Fluoromisonidazole in tumor hypoxia imaging
por: Xu, Zuoyu, et al.
Publicado: (2017)

[(18)F]Fluoromisonidazole PET in rectal cancer
por: Puri, Tanuj, et al.
Publicado: (2017)

Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen
por: Inubushi, Masayuki, et al.
Publicado: (2020)

Satisfied quantitative value can be acquired by short-time bone SPECT/CT using a whole-body cadmium–zinc–telluride gamma camera
por: Yamane, Tomohiko, et al.
Publicado: (2021)

Biological characteristics of intratumoral [F-18]-fluoromisonidazole distribution in a rodent model of glioma
por: HATANO, TOSHIYUKI, et al.
Publicado: (2013)

[(18)F]FMISO PET/CT as a preoperative prognostic factor in patients with pancreatic cancer
por: Yamane, Tomohiko, et al.
Publicado: (2019)

TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling
por: Kawabata, Hidetaka, et al.
Publicado: (2017)

(18)F-fluoromisonidazole predicts evofosfamide uptake in pancreatic tumor model
por: Grkovski, Milan, et al.
Publicado: (2018)

Imaging of hypoxia in human glioblastoma with dynamic 18F-fluoromisonidazole PET
por: Abdo, Redha-Alla, et al.
Publicado: (2019)

Correlation of Tumor Hypoxia Metrics Derived from (18)F-Fluoromisonidazole Positron Emission Tomography and Pimonidazole Fluorescence Images of Optically Cleared Brain Tissue
por: Scarpelli, Matthew L., et al.
Publicado: (2020)

Monitoring vascular normalization induced by antiangiogenic treatment with 18F‐fluoromisonidazole‐PET
por: Hernández-Agudo, Elena, et al.
Publicado: (2015)

Evaluation of hypoxia in an experimental rat tumour model by [(18)F]Fluoromisonidazole PET and immunohistochemistry
por: Dubois, L, et al.
Publicado: (2004)

Reproducibility of (18)F-fluoromisonidazole intratumour distribution in non-small cell lung cancer
por: Grkovski, Milan, et al.
Publicado: (2016)

[(18)F] fluoromisonidazole and [(18)F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study
por: Gagel, Bernd, et al.
Publicado: (2006)

A prospective clinical trial of tumor hypoxia imaging with (18)F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy
por: Tachibana, Izumi, et al.
Publicado: (2013)

Intratumoral Injection of Anlotinib Hydrogel Combined With Radiotherapy Reduces Hypoxia in Lewis Lung Carcinoma Xenografts: Assessment by Micro Fluorine-18-fluoromisonidazole Positron Emission Tomography/Computed Tomography Hypoxia Imaging
por: Gao, Qin, et al.
Publicado: (2021)

Value of (18)F-FDG-PET to predict PD-L1 expression and outcomes of PD-1 inhibition therapy in human cancers
por: Kaira, Kyoichi, et al.
Publicado: (2021)

Tumor budding and fibrotic focus—proposed grading system for tumor budding in invasive carcinoma no special type of the breast
por: Hiratsuka, Miyuki, et al.
Publicado: (2022)

Multiparametric [(18)F]Fluorodeoxyglucose/ [(18)F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study
por: Pinker, Katja, et al.
Publicado: (2016)

Kinetic analysis of dynamic (18)F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer
por: Thorwarth, Daniela, et al.
Publicado: (2005)

Evaluating cardiac hypoxia in hibernating myocardium: Comparison of (99m)Tc-MIBI/(18)F-fluorodeoxyglucose and (18)F-fluoromisonidazole positron emission tomography-computed tomography in relation to normal, hibernating, and infarct myocardium
por: Jagtap, Rajlaxmi, et al.
Publicado: (2019)

Discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and (18)F fluorodeoxyglucose positron emission tomography
por: Fukushima, Kenji, et al.
Publicado: (2019)

Quantitative evaluation of oxygen metabolism in the intratumoral hypoxia: (18)F-fluoromisonidazole and (15)O-labelled gases inhalation PET
por: Watabe, Tadashi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_22pvdf7oace1r4i2grjgmph17i